BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Approvals
FDA Approves Merck & Co., Inc. (MRK)'s Grass Pollen Pill GRASTEK® 4/15/2014 6:49:31 AM    More...
FDA Approves GlaxoSmithKline (GSK)'s Tanzeum To Treat Type 2 Diabetes 4/15/2014 9:17:52 AM    More...
Par Pharmaceutical, Inc. Begins Shipment Of Potassium Chloride Extended-Release Capsules 4/8/2014 8:11:59 AM    More...
Teva Pharmaceutical Industries Limited (TEVA) First Approval And Launch Of Generic Lovaza® Capsules In The United States 4/8/2014 8:50:07 AM    More...
Boehringer Ingelheim Pharmaceuticals, Inc. Release: FDA Approves Pradaxa® (Dabigatran Etexilate Mesylate) For Treatment And Reduction In The Risk Of Recurrence Of Deep Venous Thrombosis And Pulmonary Embolism 4/7/2014 8:53:52 AM    More...
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In The European Union For A 2-Dose Schedule In Children Aged From 9 To 13 Years 4/7/2014 3:11:39 PM    More...
Dyax Corp. (DYAX) Receives FDA Approval To Expand Use Of KALBITOR® (Ecallantide) For The Treatment Of Acute Attacks Of Hereditary Angioedema To Patients 12 Years Of Age And Older 4/4/2014 8:13:31 AM    More...
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Luxembourg 4/3/2014 8:20:44 AM    More...
FDA Approves Kaleo's Hand-Held Auto-Injector To Reverse Opioid Overdose 4/3/2014 8:57:30 AM    More...
Stallergenes, S.A. (GENP.PA) Wins FDA's Go-Ahead For Oralair Allergy Pill 4/2/2014 7:36:14 AM    More...
FDA OKs Janssen Pharmaceutical Inc. 's Topamax For Migraine Prevention In Adolescents 3/28/2014 2:48:04 PM    More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets Approval For Influenza Vaccines 3/31/2014 8:13:10 AM    More...
Pfizer Inc. (PFE) Statement On FDA Approval Of Over-the-Counter Nexium® 24HR 3/31/2014 7:08:58 AM    More...
Swedish Orphan Biovitrum: FDA Approves Alprolix™ 3/31/2014 9:56:15 AM    More...
FDA Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Hemophilia B Drug Alprolix 3/28/2014 5:26:56 PM    More...
1234567
 

//-->